Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shibata, T.
Right arrow Articles by Hirohashi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shibata, T.
Right arrow Articles by Hirohashi, S.
Clinical Cancer Research Vol. 11, 6177-6185, September 1, 2005
© 2005 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Genetic Classification of Lung Adenocarcinoma Based on Array-Based Comparative Genomic Hybridization Analysis: Its Association with Clinicopathologic Features

Tatsuhiro Shibata1, Satomi Uryu2, Akiko Kokubu1, Fumie Hosoda2, Misao Ohki2, Tokuki Sakiyama3, Yoshihiro Matsuno5, Ryosuke Tsuchiya6, Yae Kanai1, Tadashi Kondo4, Issei Imoto7,8, Johji Inazawa7,8 and Setsuo Hirohashi1

Authors' Affiliations: 1 Pathology Division, 2 Cancer Genomics Project, 3 Center for Medical Genetics, 4 Cancer Proteomics Project, National Cancer Center Research Institute, Tokyo, Japan; 5 Clinical Laboratory and 6 Thoracic Surgery Divisions, National Cancer Center Hospital, Tokyo, Japan; 7 Department of Molecular Cytogenetics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan; and 8 Core Research for Evolutional Science and Technology of Japan, Science and Technology Corporation, Saitama, Japan

Requests for reprints: Setsuo Hirohashi, Pathology Division, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, 104-0045 Tokyo, Japan. Phone: 81-3-3547-5201, ext. 4101; Fax: 81-3-3248-2463; E-mail: shirohas{at}ncc.go.jp.

The array-based comparative genomic hybridization using microarrayed bacterial artificial chromosome clones allows high-resolution analysis of genome-wide copy number changes in tumors. To analyze the genetic alterations of primary lung adenocarcinoma in a high-throughput way, we used laser-capture microdissection of cancer cells and array comparative genomic hybridization focusing on 800 chromosomal loci containing cancer-related genes. We identified a large number of chromosomal numerical alterations, including frequent amplifications on 7p12, 11q13, 12q14-15, and 17q21, and two homozygous deletions on 9p21 and one on 8p23. Unsupervised hierarchical clustering analysis of multiple alterations revealed three subgroups of lung adenocarcinoma that were characterized by the accumulation of distinct genetic alterations and associated with smoking history and gender. The mutation status of the epidermal growth factor receptor (EGFR) gene was significantly associated with specific genetic alterations and supervised clustering analysis based on EGFR gene mutations elucidated a subgroup including all EGFR gene mutated tumors, which showed significantly shorter disease-free survival. Our results suggest that there exist multiple molecular carcinogenesis pathways in lung adenocarcinoma that may associate with smoking habits and gender, and that genetic cancer profiling will reveal previously uncharacterized genetic heterogeneity of cancer and be beneficial in estimating patient prognosis and discovering novel cancer-related genes including therapeutic targets.




This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Yatabe, T. Takahashi, and T. Mitsudomi
Epidermal Growth Factor Receptor Gene Amplification Is Acquired in Association with Tumor Progression of EGFR-Mutated Lung Cancer
Cancer Res., April 1, 2008; 68(7): 2106 - 2111.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. A. Engelman, K. Zejnullahu, T. Mitsudomi, Y. Song, C. Hyland, J. O. Park, N. Lindeman, C.-M. Gale, X. Zhao, J. Christensen, et al.
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
Science, May 18, 2007; 316(5827): 1039 - 1043.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
A. Pandita, A. Balasubramaniam, R. Perrin, P. Shannon, and A. Guha
Malignant and benign ganglioglioma: A pathological and molecular study
Neuro-oncol, April 1, 2007; 9(2): 124 - 134.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Katoh, T. Shibata, A. Kokubu, H. Ojima, M. Fukayama, Y. Kanai, and S. Hirohashi
Epigenetic Instability and Chromosomal Instability in Hepatocellular Carcinoma
Am. J. Pathol., April 1, 2006; 168(4): 1375 - 1384.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.